Skip to main content
Home
OUR XCHANGES
LIFE SCIENCES
BY TOPIC
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY THERAPEUTICS
ANTIBODY CMC DEVELOPMENT
CNS THERAPEUTICS
OLIGONUCLEOTIDES & PEPTIDES
BY LOCATION
BOSTON, USA
SAN FRANCISCO, USA
PAST EVENTS
INDUSTRY EXPERTS
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY DRUG CONJUGATES THERAPEUTICS
ANTIBODY MANUFACTURING
ANTIBODY THERAPEUTICS
CNS DISCOVERY
IMMUNOTHERAPIES
MEDTECH STRATEGY
OLIGONUCLEOTIDES & PEPTIDES
NEWS XCHANGE
PARTNERSHIPS
OUR PARTNERS
BECOME A PARTNER
MEDIA PARTNERS
ABOUT US
GET TO KNOW US
FAQS
MEET THE TEAM
GALLERY
CONTACT US
Home
OUR XCHANGES
LIFE SCIENCES
BY TOPIC
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY THERAPEUTICS
ANTIBODY CMC DEVELOPMENT
CNS THERAPEUTICS
OLIGONUCLEOTIDES & PEPTIDES
BY LOCATION
BOSTON, USA
SAN FRANCISCO, USA
PAST EVENTS
INDUSTRY EXPERTS
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY DRUG CONJUGATES THERAPEUTICS
ANTIBODY MANUFACTURING
ANTIBODY THERAPEUTICS
CNS DISCOVERY
IMMUNOTHERAPIES
MEDTECH STRATEGY
OLIGONUCLEOTIDES & PEPTIDES
NEWS XCHANGE
PARTNERSHIPS
OUR PARTNERS
BECOME A PARTNER
MEDIA PARTNERS
ABOUT US
GET TO KNOW US
FAQS
MEET THE TEAM
GALLERY
CONTACT US
Sponsorship Enquiry
Register For Free
Home
OUR XCHANGES
LIFE SCIENCES
BY TOPIC
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY THERAPEUTICS
ANTIBODY CMC DEVELOPMENT
CNS THERAPEUTICS
OLIGONUCLEOTIDES & PEPTIDES
BY LOCATION
BOSTON, USA
SAN FRANCISCO, USA
PAST EVENTS
INDUSTRY EXPERTS
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY DRUG CONJUGATES THERAPEUTICS
ANTIBODY MANUFACTURING
ANTIBODY THERAPEUTICS
CNS DISCOVERY
IMMUNOTHERAPIES
MEDTECH STRATEGY
OLIGONUCLEOTIDES & PEPTIDES
NEWS XCHANGE
PARTNERSHIPS
OUR PARTNERS
BECOME A PARTNER
MEDIA PARTNERS
ABOUT US
GET TO KNOW US
FAQS
MEET THE TEAM
GALLERY
CONTACT US
Advanced Therapies Xchange - San Francisco - 2026
Loading
Translational challenges in predictive preclinical models (Topic TBC)
08 Sept 2026
15:45 - 16:15
Cell Therapy Development
Add to Calendar
LinkedIn
YouTube
Search
Search
Search
Username *
Password *
Login
